AMANDA STARK: Open Payments
NPI 1316414642 · MAUMELLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,121 in 71 payments from 13 companies in 2025. Trend: 2023 $532 · 2024 $871 · 2025 $1,121
Food & beverage: $1,121
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $220 |
| AstraZeneca Pharmaceuticals LP | 8 | $170 |
| Novo Nordisk Inc | 12 | $164 |
| Currax Pharmaceuticals LLC | 17 | $164 |
| PFIZER INC. | 7 | $128 |
| Lilly USA, LLC | 4 | $64 |
| Phathom Pharmaceuticals, Inc. | 3 | $59 |
| Dexcom, Inc. | 2 | $38 |
| Exact Sciences Corporation | 2 | $34 |
| SANOFI-AVENTIS U.S. LLC | 1 | $28 |
Products named: ONZETRA XSAIL, QULIPTA, AIRSUPRA, Wegovy, NURTEC ODT, FARXIGA, VOQUEZNA, MOUNJARO.
Industry payments across AR — which companies pay providers there.
